Chantix Now Linked To Heart Problems
A new study by researchers at Johns Hopkins University found that Pfizer's anti-smoking pill Chantix causes a 72 percent increase in the risk of heart problem-related hospitalizations. The U.S. Food and Drug Administration (FDA) previously had warned of increased risk or suicide and erratic behavior in 2009, and as recently as last month added a warning for users with a history of heart disease, but this new study suggests users even without a history of heart disease are at risk.
It is hard not to recognize the irony of this new study and the recent FDA warnings regarding heart disease. A drug that is designed to help people quit smoking, which directly leads to heart disease, causes the very thing it is designed to prevent. Currently, there are multiple lawsuits that have been filed against the makers and distributers of Chantix.
Dangerous and defective drugs are responsible for many injuries and deaths nationwide. Our profession calls this area of law products liability. Consulting an attorney experienced in handling these matters is usually easy. Most lawyers will provide a complimentary initial consultation to evaluate a claim or case and let the person know if they can help.
This consumer protection information is provided by Louisville, Kentucky attorney Will Nefzger, a partner at Bahe Cook Cantley & Nefzger PLC.
